Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04921501

Evaluation of Electrocardiographic Measurements by High Density Electrode ECG

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,800 (estimated)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

Cardiac electrical activity is detected on the body surface with conventional electrocardiography involving 12 leads (ECG 12). A limitation of the current ECG technique is that recordings are obtained from only 6 independent precordial leads pairs ; which may miss cardiac potentials from spatially limited regions. More extensive sampling of the body surface may contribute to additional clinical information. The present study investigates the additional sensitivity of ECG using 128 body surface leads (High Density (HD) ECG) in measuring global or regional cardiac activity.

Conditions

Interventions

TypeNameDescription
DEVICEHD ECGThis experimental procedure is a passive, non-invasive, high-density surface ECG recording using 128 skin electrodes.The electrodes are positioned on strips of 10 electrodes to be prepared with adhesive tape and coated with conductive gel before installation on the patient. The total duration of the acquisition is 10 to 30 minutes.
DEVICEConventional 12-lead ECGThis standard 12-lead ECG is defined on the HD ECG, from electrodes F13, G3, G14, H5, H15, H25 corresponding to the precordial electrodes. 4 limb electrodes will be added for the frontal leads. Thus, the HD and 12-lead ECGs will be obtained simultaneously.

Timeline

Start date
2021-04-06
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2021-06-10
Last updated
2024-12-24

Locations

11 sites across 2 countries: France, Monaco

Source: ClinicalTrials.gov record NCT04921501. Inclusion in this directory is not an endorsement.